Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Dayan, B.
Right arrow Articles by Nesher, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dayan, B.
Right arrow Articles by Nesher, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Q J Med 2003; 96: 53-56
© 2003 Association of Physicians

Decreased salivary output in patients with Gaucher disease

B. Dayan1, D. Elstein1,, A. Zimran1,2 and G. Nesher2

From the 1 Gaucher Clinic and 2 Department of Medicine, Shaare Zedek Medical Center, Jerusalem, Israel

Received 7 June 2002 and in revised form 9 September 2002

Background: Gaucher disease, the most common sphingolipid storage disease, results in accumulation of glucocerebroside in macrophages or ‘Gaucher cells’. In a preliminary screening of 109 patients with type I disease, when asked specifically about dry mouth, approximately one quarter claimed to suffer from this symptom.

Aim: To ascertain whether decreased salivary output is a feature of Gaucher disease.

Design: Prospective case-control study.

Methods: Salivary output was measured in 65 adult patients and 65 healthy controls using the Saxon test with Hochberg's modification.

Results: Mean salivary output was 1.91±1.19 g/min in the patient group vs. 2.74±1.17 g/min in the control group (p<0.001). This difference was greater among males. These results were not improved in the patients receiving enzyme replacement therapy, which is effective in ameliorating most Gaucher-related signs and symptoms.

Discussion: Recent studies have implicated an association between sicca syndrome and viral hepatitis C infection, which may imply an immunological trigger for these findings, but in this specific cohort, only three patients were reactive for hepatitis C. Follow-up of patients, both untreated and receiving enzyme therapy, is needed to delineate the association with salivary hypofunction, and ascertain whether enzyme therapy may induce sicca symptoms.

Address correspondence to Dr D. Elstein, Gaucher Clinic, Shaare Zedek Medical Center, POB 3235, Jerusalem 91031, Israel. e-mail: gaucher{at}szmc.org.il


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.